Saliladja, Sabriya T.
HRN: 23-34-10 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
04/09/2024
04/15/2024
PO
2.5ml
BID
UTI
Checking Final Appropriateness